PACIFIC SHUANGLINPACIFIC SHUANGLINPACIFIC SHUANGLIN

PACIFIC SHUANGLIN

No trades
See on Supercharts

000403 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the research, development, production and marketing of blood products. It specializes in the human serum albumin, intravenous human immunoglobulin, human immunoglobulin, human hepatitis B immunoglobulin, tetanus human immunoglobulin, human coagulation factor VIII, human prothrombin complex and rabies immunoglobulin. The company was founded on December 28, 1993 and is headquartered in Zhanjiang, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
000403 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company